The correlation of HIGD2A high expression and poor patient survival is significant for liver hepatocellular carcinoma; cutaneous skin melanoma; uterine corpus endometrial carcinoma; and uveal melanoma (Figure 8). The gene discussed is HIGD2A; the disease is cutaneous melanoma.